SMTL ID : 7auv.1

The structure of ERK2 in complex with dual inhibitor ASTX029

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.76 Å

Oligo State

monomer

Ligands

3 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 3 residues within 4Å: Chain A: R.199, R.202, Y.241 5 PLIP interactions: 5 interactions with chain A Water bridges: A:A.197, A:R.199, A:R.202 Salt bridges: A:R.199, A:R.202 SO4.2: 4 residues within 4Å: Chain A: Y.121, K.159, S.161, T.198 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.161 Salt bridges: A:K.159 SO4.3: 3 residues within 4Å: Chain A: H.69, Q.70, T.71 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:T.71, A:T.71 Water bridges: A:Q.70, A:Q.70 Salt bridges: A:H.69

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.4: 6 residues within 4Å: Chain A: L.124, K.125, T.126, Q.127, H.128, N.232 No protein-ligand interaction detected (PLIP)

1 x RYW: (2~{R})-2-[5-[5-chloranyl-2-(oxan-4-ylamino)pyrimidin-4-yl]-3-oxidanylidene-1~{H}-isoindol-2-yl]-~{N}-[(1~{S})-1-(3-fluoranyl-5-methoxy-phenyl)-2-oxidanyl-ethyl]propanamide(Non-covalent)

RYW.5: 24 residues within 4Å: Chain A: I.39, A.43, Y.44, V.47, A.60, K.62, I.64, P.66, Y.72, R.75, T.76, E.79, Q.113, D.114, L.115, M.116, E.117, T.118, D.119, K.122, L.164, C.174, D.175, G.177 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:I.39, A:Y.44, A:Y.44, A:V.47, A:Y.72 Hydrogen bonds: A:K.62, A:R.75, A:M.116, A:M.116, A:K.122, A:D.175, A:D.175, A:D.175, A:G.177 Water bridges: A:Y.44 Halogen bonds: A:Q.113

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Munck, J.M. et al., ASTX029, a Novel Dual-mechanism ERK Inhibitor, Modulates Both the Phosphorylation and Catalytic Activity of ERK. Mol.Cancer Ther. (2021)

Release Date

2021-10-06

Peptides

Mitogen-activated protein kinase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 1

Related Entries With Identical Sequence